Liver function tests (LFTs)—often called liver blood tests—are a group of blood markers that help doctors detect liver injury, assess how well the liver is working, and monitor recovery or progression over time. Used correctly, LFTs can flag silent problems early and guide next steps such as imaging, viral hepatitis testing, or fibrosis assessment.

What’s included in “LFTs”?

Most panels report some or all of the following:

Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) – enzymes released when liver cells are injured. Marked ALT/AST elevation usually indicates hepatocellular injury.
Alkaline phosphatase (ALP) and Gamma-glutamyl transferase (GGT) – rise with problems in bile formation or flow (cholestasis) and can also increase in certain bone disorders (ALP).
Total and direct (conjugated) bilirubin – elevated when the liver can’t process or excrete bile properly, or when there is excess red cell breakdown.
Albumin – a protein made by the liver; low levels suggest reduced synthetic function or chronic disease.
Prothrombin time / INR – reflects the liver’s ability to make clotting factors; prolonged INR signals impaired synthetic capacity and can be urgent.

ALT (SGPT) and AST (SGOT): what is normal, and what does a high value mean?

SGPT is the older name for ALT, and SGOT is the older name for AST. Indian lab reports often use both names. Each lab prints its own reference range next to the result, so always compare with the range on your report.

Test	Typical lab reference range*	What a high value can mean
ALT (SGPT)	Varies by lab; the upper limit printed on reports is usually somewhere between the 30s and 50s U/L. A US guideline suggests a "healthy" upper limit of about 29–33 U/L for men and 19–25 U/L for women.	Liver cell injury: most often fatty liver, also viral hepatitis, alcohol, medicines or supplements
AST (SGOT)	Varies by lab; usually a similar upper limit to ALT	Liver injury, but also muscle injury or heavy exercise; AST higher than ALT (about 2:1) suggests alcohol-related liver disease

*Ranges differ between laboratories and methods. Use the range printed on your own report.

Mildly high (less than about 5 times the upper limit): very common. The most frequent cause in India is fatty liver; others include alcohol, hepatitis B or C, medicines and herbal supplements, and thyroid or celiac disease. Your doctor will usually repeat the test and check for these causes.
Moderately to very high (more than 5 to 15 times the limit): suggests more active liver injury, such as acute viral hepatitis, drug-induced liver injury or a blocked bile duct. See a doctor promptly.
Any rise with jaundice, confusion, vomiting or bleeding: needs urgent medical care.

A high SGPT does not always mean serious disease, and a normal SGPT does not rule out liver scarring. If your SGPT stays high or you have fatty liver, a liver specialist may advise an ultrasound, hepatitis tests and a fibrosis check such as FibroScan. See also fatty liver causes and treatment.

When are LFTs recommended?

Doctors order LFTs when you:

Have symptoms (jaundice, dark urine, pale stools, itching, fatigue, right-upper-quadrant pain)
Have risk factors (alcohol use disorder, viral hepatitis exposure, obesity/metabolic syndrome, certain medications or supplements)
Need monitoring for a known liver disease or a potentially liver-toxic medication
As part of a routine panel, where an unexpected abnormality may appear

Guidelines emphasize interpreting any abnormal result in a clinical context and confirming with repeat testing or additional work-up rather than ignoring “mild” abnormalities.

How to prepare for an LFT

A colonoscopy is done to find and prevent serious stomach and intestinal issues. Doctors recommend it forUsually, no special preparation is required. Your clinician may ask about recent alcohol intake, strenuous exercise, medicines/supplements, and fasting status because these can subtly influence results; patient-facing instructions are summarized by MedlinePlus

Understanding LFT patterns

Doctors first look at the pattern of abnormalities:

Hepatocellular pattern – ALT/AST disproportionately high compared with ALP (think viral hepatitis, ischemia, toxins, autoimmune hepatitis, fatty liver flares).
Cholestatic pattern – ALP and GGT predominate (think gallstones, biliary obstruction, primary biliary cholangitis or sclerosing cholangitis, drug-induced cholestasis).
Mixed pattern – both sets elevated.
Impaired synthetic function – low albumin and/or prolonged INR (seen in advanced or acute severe liver disease).

The magnitude of the enzyme rise helps triage urgency. AASLD suggests an initial work-up with CBC, ALT/AST, ALP, bilirubin, PT/INR, viral hepatitis panel, iron studies, and abdominal ultrasound—escalating to autoimmune and other testing if elevations are persistent or significant.

Common causes of abnormal LFTs

Metabolic dysfunction–associated steatotic liver disease (MASLD/NAFLD) – linked to obesity, diabetes, dyslipidemia; typically mild ALT>AST elevations.
Alcohol-related liver disease – AST often > ALT (classically ~2:1).
Viral hepatitis (A, B, C, E) – may cause marked hepatocellular elevations.
Drug- or supplement-induced liver injury (DILI) – patterns vary; careful medication/supplement history is key. FDA guidance underscores frequent early monitoring when starting drugs with potential hepatotoxicity.
Biliary tract disease (stones, strictures, tumors) – cholestatic pattern with raised ALP/GGT and bilirubin.
Autoimmune liver diseases (AIH, PBC, PSC) – may present with any pattern; require specific serologies and sometimes biopsy.
Ischemic or congestive hepatopathy, muscle disorders (can spuriously raise AST/ALT), celiac disease, and thyroid disorders are less common but important.

Monitoring: what changes over time?

ALT/AST generally fall as hepatocellular injury resolves.
ALP falls slowly (half-life ≈ 7 days), so it can stay elevated for weeks after obstruction or cholestatic injury improves—useful when counseling patients on recovery timelines.
Bilirubin may lag behind transaminases in cholestasis; INR and albumin track liver synthetic function and prognosis.

How often to repeat? It depends on the diagnosis and treatment. In potential DILI, regulators advise checking enzymes and bilirubin every 2–4 weeks early after starting a suspect drug. In chronic diseases, the cadence is tailored to risk and therapy.

What happens after an abnormal result?

Evidence-based algorithms (BSG, AASLD, ACG) recommend:

Confirm and characterize: repeat LFTs (unless severely abnormal), review medications/alcohol, screen for viral hepatitis, check metabolic risks, and perform an ultrasound if cholestasis or persistent abnormalities.
Stratify fibrosis risk: in at-risk patients (e.g., MASLD, alcohol-related disease), use non-invasive fibrosis scores such as FIB-4 as a first step to rule out advanced fibrosis; if elevated, follow with elastography (FibroScan/VCTE) or second-tier tests per EASL’s 2021 algorithm.
Targeted testing: autoimmune markers (ANA, ASMA, AMA), iron studies, ceruloplasmin (young patients), alpha-1 antitrypsin, celiac serologies—guided by age, pattern, and clinical clues.
Refer when needed: urgent referral for jaundice with high INR, suspected acute liver failure, or evidence of advanced chronic disease.

Special situations

Pregnancy: ALP can be physiologically higher (placental source). Persistently abnormal bile acids or LFTs warrant evaluation for intrahepatic cholestasis of pregnancy.
Children: age-specific ranges and pediatric causes differ; follow pediatric-specific guidance.
Athletes / intense exercise: can transiently raise AST/ALT; interpreting alongside CK and history helps differentiate muscle vs liver origin.
Bone disease: isolated ALP elevation with normal GGT suggests a bone source rather than liver.

Limitations of LFTs

“Normal LFTs” ≠ “normal liver”. Fibrosis can be present with normal enzymes. That’s why risk-based fibrosis assessment (FIB-4 → elastography) is recommended in primary care for at-risk groups.
Not specific to a single diagnosis. The pattern + history + imaging/serology is what makes the picture clear.
Reference ranges vary by lab and population; always interpret against your lab’s cut-offs.

Frequently Asked Questions (FAQs)

1. Can fatty liver be diagnosed from LFTs alone?

No. LFTs can be normal in fatty liver. Diagnosis relies on imaging (ultrasound, CAP on FibroScan) and metabolic risk assessment; fibrosis risk is staged with non-invasive tests per EASL.

2. Do supplements matter?

Yes—herbal and bodybuilding products are common causes of DILI. Bring a complete list (including “natural” products) to your visit. Early monitoring is advised when a product is suspected

3. How fast will my numbers normalize after a blockage or cholestatic injury?

N ALP can take weeks to come down because of its ~7-day half-life, even after the obstruction is treated..

4. Which abnormalities are most urgent?

Jaundice with INR prolongation, very high bilirubin, or signs of acute liver failure need same-day assessment. Guideline pathways from BSG/AASLD/ACG support urgent work-up in these scenarios. Easily Digestible Indian Foods can help.

5. What happens if the test results are abnormal?

If your doctor finds anything unusual, they will discuss the next steps, which may include further tests or treatment.

A Complete Guide to Liver Function Tests for Diagnosis and Monitoring